Céline Callens

7PUBLICATIONS
12CO-AUTHORS
Molecular targetsHaematological tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 27, 2024
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis.

Antoine Vasseur, Luc Cabel, Caroline Hego

|Nov 09, 2023
Shallow whole genome sequencing approach to detect Homologous Recombination Deficiency in the PAOLA-1/ENGOT-OV25 phase-III trial.

Celine Callens, Manuel Rodrigues, Adrien Briaux

|Apr 13, 2022
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.

Celine Callens, Francois-Clement Bidard, Anaïs Curto-Taribo

|Dec 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.

Céline Callens, Dominique Vaur, Isabelle Soubeyran

|Mar 13, 2019
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.

Florence Coussy, Leanne de Koning, Marion Lavigne

|Oct 12, 2018
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).

Xu Liang, Adrien Briaux, Véronique Becette

Pageof 2

Frequent Collaborators

2 joint publications

Isabelle Ray-Coquard

1 joint publications

Florence Coussy

1 joint publications

Etienne Rouleau

1 joint publications

Nicolas Sevenet